Global fibrinolytic capacity in patients with subclinical hypothyroidism

dc.authorwosidTurgut, Burhan/A-2517-2016
dc.contributor.authorGuldiken, S
dc.contributor.authorDemir, M
dc.contributor.authorTurgut, B
dc.contributor.authorAltun, BU
dc.contributor.authorArikan, E
dc.contributor.authorKara, M
dc.date.accessioned2024-06-12T11:15:46Z
dc.date.available2024-06-12T11:15:46Z
dc.date.issued2005
dc.departmentTrakya Üniversitesien_US
dc.description.abstractSubclinical hypothyroidism (SH) represents the earliest stages of hypothyroidism but the benefits of detecting and treating SH are not well known. The aim of this Study was to evaluate the alterations in global fibrinolytic capacity (GFC), which indicates the overall fibrinolytic activity, in patients with SH. The study group comprised of 15 patients with SH and 15 healthy controls. The GFC was significantly lower in patients with SH than in control group (p < 0.002). This result suggests a relative hypercoagulable state in SH.en_US
dc.identifier.doi10.1507/endocrj.52.363
dc.identifier.endpage367en_US
dc.identifier.issn0918-8959
dc.identifier.issue3en_US
dc.identifier.pmid16006731en_US
dc.identifier.scopus2-s2.0-22344452880en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage363en_US
dc.identifier.urihttps://doi.org/10.1507/endocrj.52.363
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24066
dc.identifier.volume52en_US
dc.identifier.wosWOS:000230338000010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherJapan Endocrine Societyen_US
dc.relation.ispartofEndocrine Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSubdinical Hypothyroidismen_US
dc.subjectGlobal Fibrinolytic Capacityen_US
dc.subjectHypothyroidismen_US
dc.subjectFibrinolytic Systemen_US
dc.subjectThyroid-Diseaseen_US
dc.subjectRisk-Factoren_US
dc.subjectCardiovascular-Diseaseen_US
dc.subjectMyocardial-Infarctionen_US
dc.subjectHemostatic Systemen_US
dc.subjectPlasmaen_US
dc.subjectStateen_US
dc.subjectAtherosclerosisen_US
dc.subjectEpidemiologyen_US
dc.subjectMarkersen_US
dc.titleGlobal fibrinolytic capacity in patients with subclinical hypothyroidismen_US
dc.typeArticleen_US

Dosyalar